FMS — Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) price, chart and key statistics

Price data

Price

$21.41

YTD price return

-10.12%

YTD total return

-6.49%

Next earnings

Nov 3, 2026 · Before open

Market cap

6B2016-12 12.9B2026-10 6B-53.6% over the window

Enterprise value

12.7B

Shares outstanding

279.3M2015-12 305.3M2025-12 279.3M-8.5% over the window

52W low

$20.02

52W high

$27.43

From 52W high

-21.95%

From 52W low

+6.94%

52W range

19%

Volume

Rel volume

5.87×

30D volume

1.1M

30D $ vol

23.1M

Fundamentals

Sales (ttm)

22.2B2015-12 17.2B2025-12 22.2B+29.5% over the window

Sales/share

$79.522015-12 $56.192025-12 $79.52+41.5% over the window

EPS (ttm)

$3.802015-12 $3.472025-12 $3.80+9.4% over the window

FCF (ttm)

1.8B2015-12 1B2019-12 1.6B+60.3% over the window

FCF/share

$6.352015-12 $3.302019-12 $5.41+64.0% over the window

Book value/share

$56.032015-12 $32.382025-12 $56.03+73.0% over the window

Net margin

6.07%2015-12 7.8%2025-12 6.1%-22.5% over the window

ROE

8.61%2015-12 13.6%2025-12 8.6%-36.6% over the window

ROA

3.70%2015-12 5.3%2025-12 3.7%-30.2% over the window

Debt / equity

0.43×2015-12 0.792025-12 0.43-46.2% over the window

Current ratio

1.262015-12 1.632025-12 1.26-22.5% over the window

Growth (CAGR, ttm) · 10Y

Sales

+6.19%2024-12-31 → 2025-12-3120.9B → 22.2B (+6.2% total)+2.86%2022-12-31 → 2025-12-3120.4B → 22.2B (+8.8% total)+1.75%2020-12-31 → 2025-12-3120.4B → 22.2B (+9.1% total)+2.62%2015-12-31 → 2025-12-3117.2B → 22.2B (+29.5% total)

Net income

+68.26%2024-12-31 → 2025-12-31801.4M → 1.3B (+68.2% total)+12.73%2022-12-31 → 2025-12-31940.8M → 1.3B (+43.3% total)-3.81%2020-12-31 → 2025-12-311.6B → 1.3B (-17.7% total)+0.03%2015-12-31 → 2025-12-311.3B → 1.3B (+0.3% total)

FCF

+36.23%2018-12-31 → 2019-12-311.2B → 1.6B (+36.2% total)+13.39%2016-12-31 → 2019-12-311.1B → 1.6B (+45.7% total)n/an/a

Shares

-4.82%2024-12-31 → 2025-12-31293.4M → 279.3M (-4.8% total)-1.63%2022-12-31 → 2025-12-31293.4M → 279.3M (-4.8% total)-0.95%2020-12-31 → 2025-12-31292.9M → 279.3M (-4.6% total)-0.89%2015-12-31 → 2025-12-31305.3M → 279.3M (-8.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS

+92.15%2024-12-31 → 2025-12-31$1.98 → $3.80 (+92.1% total)+16.25%2022-12-31 → 2025-12-31$2.42 → $3.80 (+57.1% total)-3.38%2020-12-31 → 2025-12-31$4.51 → $3.80 (-15.8% total)+0.91%2015-12-31 → 2025-12-31$3.47 → $3.80 (+9.4% total)

Sales/share

+11.57%2024-12-31 → 2025-12-31$71.28 → $79.52 (+11.6% total)+4.57%2022-12-31 → 2025-12-31$69.55 → $79.52 (+14.3% total)+2.72%2020-12-31 → 2025-12-31$69.52 → $79.52 (+14.4% total)+3.53%2015-12-31 → 2025-12-31$56.19 → $79.52 (+41.5% total)

FCF/share

+40.13%2018-12-31 → 2019-12-31$3.86 → $5.41 (+40.1% total)+14.38%2016-12-31 → 2019-12-31$3.62 → $5.41 (+49.6% total)n/an/a

Book value/share

+8.51%2024-12-31 → 2025-12-31$51.63 → $56.03 (+8.5% total)+3.17%2022-12-31 → 2025-12-31$51.01 → $56.03 (+9.8% total)+3.53%2020-12-31 → 2025-12-31$47.10 → $56.03 (+19.0% total)+5.63%2015-12-31 → 2025-12-31$32.38 → $56.03 (+73.0% total)

Dividend/share

+33.01%2024-12-31 → 2025-12-31$1.29 → $1.71 (+33.0% total)+6.47%2022-12-31 → 2025-12-31$1.42 → $1.71 (+20.7% total)+4.60%2020-12-31 → 2025-12-31$1.37 → $1.71 (+25.2% total)+8.18%2015-12-31 → 2025-12-31$0.78 → $1.71 (+119.5% total)

Price

-20.83%2025-10-20 → 2026-10-20$27.04 → $21.41 (-20.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+6.65%2023-10-20 → 2026-10-20$17.65 → $21.41 (+21.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-9.70%2021-10-20 → 2026-10-20$35.66 → $21.41 (-40.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-6.52%2016-10-19 → 2026-10-20$42.01 → $21.41 (-49.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

-17.64%2025-10-20 → 2026-10-20$25.99 → $21.41 (-17.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+10.13%2023-10-20 → 2026-10-20$16.03 → $21.41 (+33.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-7.01%2021-10-20 → 2026-10-20$30.78 → $21.41 (-30.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.43%2016-10-19 → 2026-10-20$33.69 → $21.41 (-36.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

5.6×2016-12 9.592026-10 4.44-53.7% over the window

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.

2.9×2016-12 5.452026-10 2.89-47.0% over the window

Fwd P/E

7.4×

P/S (ttm)Market cap ÷ TTM revenue.

0.3×2016-12 0.752026-10 0.27-64.2% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

0.4×2016-12 1.302026-10 0.38-70.7% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

3.4×2016-12 12.792026-10 3.70-71.1% over the window

EV/EBITDA (fy)

3.4×

EV/Sales (ttm)

0.6×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

29.67%2016-12 8.6%2019-12 14.7%+70.9% over the window

Buyback yield (realized, 1y)1 − shares_at(2025-12-31) ÷ shares_at(2024-12-31) = 1 − 279.3M ÷ 293.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

4.82%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (4.82%) + dividends paid over that year ($478.1M) ÷ market_cap_at(2024-12-31) ($6.6B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

12.01%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($663.2M) ÷ today's market cap ($6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

11.09%2016-12 0.0%2025-12 10.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $663.2M + TTM dividends $478.1M) ÷ today's market cap ($6B). Same caveat as the cash buyback yield.

19.09%2016-12 2.2%2025-12 17.2%+697.6% over the window

Vs own 10Y history

P/E

11th

P/OI

7th

P/S

8th

P/B

10th

P/FCF

14th